Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry Sounds Somewhat Muted Drug Pricing Alarm

Executive Summary

Pharma CEOs expect the US pricing situation will remain stable in the near-term but accept drug prices will continue to face pressure and agree that the future remains uncertain. Subsiding rhetoric after elections may bring some relief.


Related Content

Calif. Prop 61 Raises Industry Concerns Over Ripple Effect
Pfizer’s Read Criticizes Rebates Amid Changing Market Dynamics
Allergan's Price Reform Pledge: Will Others Follow?


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts